These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14623001)

  • 1. MexAB-OprM-specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 1: discovery and early strategies for lead optimization.
    Nakayama K; Ishida Y; Ohtsuka M; Kawato H; Yoshida Ki; Yokomizo Y; Hosono S; Ohta T; Hoshino K; Ishida H; Yoshida K; Renau TE; Léger R; Zhang JZ; Lee VJ; Watkins WJ
    Bioorg Med Chem Lett; 2003 Dec; 13(23):4201-4. PubMed ID: 14623001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 2: achieving activity in vivo through the use of alternative scaffolds.
    Nakayama K; Ishida Y; Ohtsuka M; Kawato H; Yoshida K; Yokomizo Y; Ohta T; Hoshino K; Otani T; Kurosaka Y; Yoshida K; Ishida H; Lee VJ; Renau TE; Watkins WJ
    Bioorg Med Chem Lett; 2003 Dec; 13(23):4205-8. PubMed ID: 14623002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of MexAB-OprM efflux pump in carbapenem-resistant Pseudomonas aeruginosa.
    Pan YP; Xu YH; Wang ZX; Fang YP; Shen JL
    Arch Microbiol; 2016 Aug; 198(6):565-71. PubMed ID: 27060003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An efflux pump (MexAB-OprM) of Pseudomonas aeruginosa is associated with antibacterial activity of Epigallocatechin-3-gallate (EGCG).
    Kanagaratnam R; Sheikh R; Alharbi F; Kwon DH
    Phytomedicine; 2017 Dec; 36():194-200. PubMed ID: 29157815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to beta-lactam antibiotics in Pseudomonas aeruginosa due to interplay between the MexAB-OprM efflux pump and beta-lactamase.
    Nakae T; Nakajima A; Ono T; Saito K; Yoneyama H
    Antimicrob Agents Chemother; 1999 May; 43(5):1301-3. PubMed ID: 10223959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of efflux pump MexAB-OprM and OprD of Pseudomonas aeruginosa strains isolated from clinical samples using qRT-PCR.
    Arabestani MR; Rajabpour M; Yousefi Mashouf R; Alikhani MY; Mousavi SM
    Arch Iran Med; 2015 Feb; 18(2):102-8. PubMed ID: 25644798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linkage of the efflux-pump expression level with substrate extrusion rate in the MexAB-OprM efflux pump of Pseudomonas aeruginosa.
    Narita S; Eda S; Yoshihara E; Nakae T
    Biochem Biophys Res Commun; 2003 Sep; 308(4):922-6. PubMed ID: 12927807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mode of action of 2-(thiazol-2-ylthio)-1beta-methylcarbapenems against Pseudomonas aeruginosa: the impact of outer membrane permeability and the contribution of MexAB-OprM efflux system.
    Eguchi K; Ueda Y; Kanazawa K; Sunagawa M; Gotoh N
    J Antibiot (Tokyo); 2007 Feb; 60(2):129-35. PubMed ID: 17420563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrolide antibiotic-mediated downregulation of MexAB-OprM efflux pump expression in Pseudomonas aeruginosa.
    Sugimura M; Maseda H; Hanaki H; Nakae T
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4141-4. PubMed ID: 18676884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of activity of ceftazidime-avibactam due to MexAB-OprM efflux and overproduction of AmpC cephalosporinase in Pseudomonas aeruginosa isolated from patients suffering from cystic fibrosis.
    Chalhoub H; Sáenz Y; Nichols WW; Tulkens PM; Van Bambeke F
    Int J Antimicrob Agents; 2018 Nov; 52(5):697-701. PubMed ID: 30081137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of sulbactam on anti-pseudomonal activity of beta-lactam antibiotics in cells producing various levels of the MexAB-OprM efflux pump and beta-lactamase.
    Nakae T; Saito K; Nakajima A
    Microbiol Immunol; 2000; 44(12):997-1001. PubMed ID: 11220688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomonas aeruginosa reveals high intrinsic resistance to penem antibiotics: penem resistance mechanisms and their interplay.
    Okamoto K; Gotoh N; Nishino T
    Antimicrob Agents Chemother; 2001 Jul; 45(7):1964-71. PubMed ID: 11408209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of the MexX-MexY-oprM efflux system to intrinsic resistance in Pseudomonas aeruginosa.
    Masuda N; Sakagawa E; Ohya S; Gotoh N; Tsujimoto H; Nishino T
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2242-6. PubMed ID: 10952562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa.
    Masuda N; Sakagawa E; Ohya S; Gotoh N; Tsujimoto H; Nishino T
    Antimicrob Agents Chemother; 2000 Dec; 44(12):3322-7. PubMed ID: 11083635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced efficacy of putative efflux pump inhibitor/antibiotic combination treatments versus MDR strains of Pseudomonas aeruginosa in a Galleria mellonella in vivo infection model.
    Adamson DH; Krikstopaityte V; Coote PJ
    J Antimicrob Chemother; 2015 Aug; 70(8):2271-8. PubMed ID: 25921513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 3: Optimization of potency in the pyridopyrimidine series through the application of a pharmacophore model.
    Nakayama K; Kawato H; Watanabe J; Ohtsuka M; Yoshida K; Yokomizo Y; Sakamoto A; Kuru N; Ohta T; Hoshino K; Yoshida K; Ishida H; Cho A; Palme MH; Zhang JZ; Lee VJ; Watkins WJ
    Bioorg Med Chem Lett; 2004 Jan; 14(2):475-9. PubMed ID: 14698185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-level fluoroquinolone resistance in Pseudomonas aeruginosa due to interplay of the MexAB-OprM efflux pump and the DNA gyrase mutation.
    Nakajima A; Sugimoto Y; Yoneyama H; Nakae T
    Microbiol Immunol; 2002; 46(6):391-5. PubMed ID: 12153116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MexAB-OprM- and MexXY-overproducing mutants are very prevalent among clinical strains of Pseudomonas aeruginosa with reduced susceptibility to ticarcillin.
    Hocquet D; Roussel-Delvallez M; Cavallo JD; Plésiat P
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1582-3. PubMed ID: 17220417
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of MexAB-OprM and MexXY-OprM efflux pumps and class 1 integrons in resistance to antibiotics in burn and Intensive Care Unit isolates of Pseudomonas aeruginosa.
    Goli HR; Nahaei MR; Rezaee MA; Hasani A; Kafil HS; Aghazadeh M; Nikbakht M; Khalili Y
    J Infect Public Health; 2018; 11(3):364-372. PubMed ID: 28993173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conessine as a novel inhibitor of multidrug efflux pump systems in Pseudomonas aeruginosa.
    Siriyong T; Srimanote P; Chusri S; Yingyongnarongkul BE; Suaisom C; Tipmanee V; Voravuthikunchai SP
    BMC Complement Altern Med; 2017 Aug; 17(1):405. PubMed ID: 28806947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.